0001209191-23-053347.txt : 20231023
0001209191-23-053347.hdr.sgml : 20231023
20231023170014
ACCESSION NUMBER: 0001209191-23-053347
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231019
FILED AS OF DATE: 20231023
DATE AS OF CHANGE: 20231023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hagen Brett R
CENTRAL INDEX KEY: 0001681782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39409
FILM NUMBER: 231340468
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE, 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allovir, Inc.
CENTRAL INDEX KEY: 0001754068
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 831971007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (617) 433-2605
MAIL ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: ViraCyte, Inc.
DATE OF NAME CHANGE: 20180924
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-19
0
0001754068
Allovir, Inc.
ALVR
0001681782
Hagen Brett R
C/O ALLOVIR, INC.
1100 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Chief Accounting Officer
1
Common Stock
2023-10-19
4
S
0
358
1.58
D
126595
D
Common Stock
2023-10-20
4
S
0
357
1.541
D
126238
D
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.53 to $1.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
/s/ Brett Hagen
2023-10-23